InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by Zygmont Chester Stanley III. Officer active across 1 company, notably Revelation Biosciences, INC.. Cumulatively, 1 disclosures have been logged. Activity tracked since 11 February 2025. The latest transaction was filed on 11 February 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
1 of 1 declaration